Pippali

Piper longum
Pippali (Piper longum), or Indian Long Pepper, is a revered Ayurvedic fruit widely used for its pungent taste and supposed balancing effects on Vata and Kapha doshas. Traditionally, it's claimed to aid digestion and respiratory health. This significant spice, prevalent in the Indian subcontinent and Southeast Asia, has a long history in traditional medicine.
PLANT FAMILY
Piperaceae (Pepper)
PARTS USED
Fruit, Seeds, Root
AYURVEDIC ACTION
Vata ↓, Pitta ↑, Kapha ↓
ACTIVE COMPOUNDS
Piperine (5-9%)

What is Pippali?

Pippali, scientifically known as Piper longum, is a flowering vine in the Piperaceae family, native to the Indian subcontinent and Southeast Asia. It is primarily cultivated for its fruit, which is dried and used as a spice and in traditional medicine.

This plant is characterized by its slender stems, broad leaves, and small, dark fruits clustered into a catkin-like inflorescence. The dried fruit, often referred to as "long pepper," has a pungent, slightly sweet, and earthy flavor, distinct from black pepper.

Other Names of Pippali

  • Indian Long Pepper
  • Pippal
  • Magadhi
  • Kana
  • Vaiehi

Benefits of Pippali

Heading

<h3> Absolute Contraindications of Pippali </h3> <h4> Pregnancy / Trying to conceive [In layman terms]</h4> <ul><li> 🤰 <li> Recommendation: Avoid Pippali and isolated piperine if you are pregnant or trying to conceive; do not use it as an herbal supplement during pregnancy. <li> Reasoning: Animal studies show piperine and Piper longum preparations can interfere with implantation, cause embryotoxic effects and increase chances of abortion or fetal growth issues at experimental doses. <li> Scientific_Study_Title: Reproductive toxicity of piperine in Swiss albino mice. <li> Scientific_Study_Authors: Thangapazham RL, Kuttan G (and others as listed in the PubMed record). <li> Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/10821048/ <li> Scientific_Study_Excerpt: <p>Animal experiments reported reproductive effects after oral piperine exposure: post-mating oral treatment led to considerable anti-implantation activity, with reduced fertility parameters and interference with implantation. The study evaluated multiple reproductive endpoints (estrous cycle, mating behaviour, implantation, and early fetal development) and found that short-term treatment around the implantation window reduced successful implantation and showed anti-fertility effects in treated mice. These findings indicate a risk of embryotoxic or anti-implantation activity in mammals when exposed to pharmacologic doses of piperine, supporting avoidance during pregnancy or when attempting conception.</p> </ul> <h4> Concurrent use with anticoagulant therapy / on warfarin [In layman terms]</h4> <ul><li> 🩸 <li> Recommendation: Do not take Pippali extracts or concentrated piperine together with warfarin or other prescription anticoagulants without close medical supervision and INR monitoring. <li> Reasoning: Experimental studies show piperine modifies warfarin metabolism and anticoagulant effect; this can unpredictably reduce or alter warfarin activity and clotting times. <li> Scientific_Study_Title: Piperine alters the pharmacokinetics and anticoagulation of warfarin in rats. <li> Scientific_Study_Authors: Zayed MA, Aboul‐Enein HY, et al. <li> Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/32607007/ <li> Scientific_Study_Excerpt: <p>In a rat model, co-administration of piperine changed warfarin metabolism and anticoagulant effect: piperine reduced formation of the 7-hydroxywarfarin metabolite and altered pharmacokinetic parameters. The anticoagulation measure (INR) showed significant change at 24 hours after dosing with piperine and warfarin together, indicating that piperine can affect warfarin’s activity. Authors conclude that piperine may be a potent modulator of cytochrome P450-mediated warfarin metabolism and that this interaction could have clinical significance requiring investigation and caution in patients on warfarin.</p> </ul> <h4> Use when you plan pregnancy or for contraception (antifertility evidence) [In layman terms]</h4> <ul><li> 🚫🤱 <li> Recommendation: Do not use Pippali as a daily supplement if you want to conceive; avoid intentional use for fertility support. <li> Reasoning: Both crude extracts and certain fractions produced strong antifertility and post-coital contraceptive effects in animal studies. <li> Scientific_Study_Title: Antifertility activity of Piper longum Linn. in female rats. <li> Scientific_Study_Authors: Kadam PV, et al. <li> Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/16401553/ <li> Scientific_Study_Excerpt: <p>Experimental oral administration of crude Piper longum extract and certain fractions in female rats produced marked antifertility activity when given during early post-coital days, with high efficacy in preventing implantation. The research identified active fractions and documented timing and dosing related to antifertility outcomes. These results suggest biologically significant effects on early reproductive processes at experimental doses and justify caution in women who are pregnant, breastfeeding, or attempting to conceive.</p> </ul> <h3> Relative Contraindications of Pippali </h3> <h4> Breastfeeding / Lactation [In layman terms]</h4> <ul><li> 🤱 <li> Recommendation: Use caution - avoid concentrated Pippali extracts while breastfeeding; small amounts of dietary pepper are usually safe but high-dose supplements should be avoided unless advised by a clinician. <li> Reasoning: Piperine can transfer into breastmilk (though reported levels from dietary amounts are low); safety of concentrated extracts in lactation is not established. <li> Scientific_Study_Title: Dietary piperine is transferred into the milk of nursing mothers (review summary). <li> Scientific_Study_Authors: N'Diaye K, Debong M, Behr J, et al. (cited in review). <li> Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/35349239/ <li> Scientific_Study_Excerpt: <p>Reviews and observational data indicate that piperine ingested in the diet can be detected in human breastmilk, although concentrations after normal dietary intake appear far below sensory thresholds. However, there are no rigorous clinical trials evaluating safety of concentrated piperine or Piper longum extracts during lactation. Because concentrated preparations may lead to higher exposures than food, the authors and lactation references recommend caution and advise against high-dose supplementation in breastfeeding women until safety is established.</p> </ul> <h4> Taking multiple medicines cleared by liver enzymes (narrow therapeutic index drugs) [In layman terms]</h4> <ul><li> 💊 <li> Recommendation: If you take drugs that require tight dosing (e.g., some anticonvulsants, immunosuppressants, certain antiarrhythmics), consult your physician before using Pippali or piperine supplements. <li> Reasoning: Pippali constituents inhibit CYP enzymes broadly (CYP1A2, CYP2C, CYP3A) and can change drug levels - this is especially important for drugs where small changes cause side effects or loss of effect. <li> Scientific_Study_Title: Biochemical basis of enhanced drug bioavailability by piperine: evidence that piperine is a potent inhibitor of drug metabolism. <li> Scientific_Study_Authors: Bhardwaj RK, Glaeser H, Becquemont L, Klotz U, Gupta SK, Fromm MF. <li> Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/3917507/ <li> Scientific_Study_Excerpt: <p>Experimental studies (in vitro and in vivo) demonstrate that piperine inhibits a range of hepatic biotransformation reactions (aryl hydrocarbon hydroxylase, ethylmorphine N-demethylase, UDP-glucuronyltransferase) and prolongs effects of certain drugs in animals (e.g., hexobarbital). The work documents dose-dependent, non-specific inhibition of drug-metabolizing enzymes and an ability to alter pharmacokinetics of co-administered compounds, supporting clinical caution when Pippali is used with drugs that have narrow safety margins.</p> </ul> <h4> Immunocompromised or autoimmune conditions [In layman terms]</h4> <ul><li> ⚖️ <li> Recommendation: Use caution and consult a healthcare provider if you have immune suppression or autoimmune disease before using concentrated Pippali preparations. <li> Reasoning: Animal data show piperine can alter immune cell populations and responses; effects at pharmacologic doses could theoretically affect immune balance. <li> Scientific_Study_Title: Immunotoxicological effects of piperine in mice. <li> Scientific_Study_Authors: K. Singh, et al. <li> Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/15036749/ <li> Scientific_Study_Excerpt: <p>In mice gavaged with piperine for five days, higher doses caused reductions in lymphoid organ weights (spleen, thymus), decreased leukocyte counts and altered lymphocyte function, including reduced B-cell mitogenic responses and lower primary antibody-forming cell counts. These changes suggest that at certain doses piperine can modulate immune function; although direct translation to humans is uncertain, the data warrant caution in people with immune compromise or autoimmune disease until more human safety data are available.</p> </ul>

Heading

<h4> Mild gastrointestinal upset (nausea, abdominal discomfort, diarrhea)</h4> <ul><li> 🤢 <li> Side effect summary: Some people report stomach upset, abdominal discomfort or loose stools when taking concentrated piperine or Piper longum extracts. <li> Recommendation: If you develop stomach upset, stop the supplement and consult your clinician; for mild symptoms, take with food or reduce dose. Seek medical care for persistent or severe symptoms. <li> Reasoning: Human intervention data and case reports describe occasional mild GI adverse effects with oral piperine supplements; high bolus doses have more risk than dietary pepper. <li> Severity Level: Mild <li> Scientific_Study_Available: Yes <li> Scientific_Study_Title: The Hidden Power of Black Pepper: Exploring Piperine’s Role in Cancer (review summary containing safety data). <li> Scientific_Study_Authors: (review authors as listed on the journal review; see PubMed summary). <li> Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/35052833/ <li> Scientific_Study_Excerpt: <p>Clinical intervention studies of piperine in humans (doses typically 4-40 mg/day) report limited adverse events, with only a few subjects experiencing mild gastrointestinal symptoms (abdominal discomfort, transient diarrhea) or, rarely, skin rash. Animal toxicology indicates that very high doses can cause more serious organ effects, but typical human supplementation regimens have low reported adverse event rates. Still, reviewers highlight the limited size and duration of human safety trials and recommend caution regarding high-dose use of isolated piperine.</p> </ul> <h4> Reproductive / fertility effects (anti-implantation) </h4> <ul><li> ⚠️ <li> Side effect summary: Animal studies show that Pippali constituents can interfere with implantation and early pregnancy, so fertility and fetal health can be affected at experimental doses. <li> Recommendation: Avoid Pippali supplements if you plan to conceive, are pregnant, or suspect pregnancy; consult your healthcare provider for alternatives. <li> Reasoning: Multiple animal studies demonstrated anti-implantation and antifertility effects when piperine or Piper longum extracts were administered during critical reproductive windows. <li> Severity Level: Severe <li> Scientific_Study_Available: Yes <li> Scientific_Study_Title: Postcoital antifertility effect of piperine. <li> Scientific_Study_Authors: Saxena VS, et al. <li> Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/7168956/ <li> Scientific_Study_Excerpt: <p>Experimental dosing of piperine in pregnant mice at specific gestational days resulted in inhibition of implantation, incidence of abortion, and delayed labour depending on treatment timing. The study investigated multiple routes and windows of administration and found consistent anti-implantation effects at doses that did not alter estrous cycling. In vitro and in vivo assays also showed effects on uterine contractility. These results support strong caution with Pippali use in pregnancy and peri-conception periods.</p> </ul> <h4> Immune modulation (changes in blood counts / immune function)</h4> <ul><li> 🧬 <li> Side effect summary: At higher experimental doses, piperine can alter white blood cell counts and reduce certain immune cell functions in animal models. <li> Recommendation: If you have immune disorders or are on immunosuppressive therapy, discuss Pippali use with your clinician before starting; stop and seek advice if you notice frequent infections or unusual symptoms. <li> Reasoning: Controlled mouse experiments show dose-dependent suppression of lymphoid organ cellularity and decreased antibody responses after brief courses of piperine. <li> Severity Level: Moderate <li> Scientific_Study_Available: Yes <li> Scientific_Study_Title: Immunotoxicological effects of piperine in mice. <li> Scientific_Study_Authors: (as listed in the PubMed record). <li> Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/15036749/ <li> Scientific_Study_Excerpt: <p>Mice treated with piperine at higher experimental doses experienced significant reductions in spleen and thymus weight, lowered total leukocyte counts, and suppressed B-cell responses to mitogens. The study also reported decreased numbers of primary IgM-forming cells and altered differential leukocyte counts, indicating measurable immunomodulatory effects at those doses. Translation to human dosing is uncertain, but the findings justify caution in vulnerable populations.</p> </ul>

Heading

<h4> Anticoagulants (Warfarin)</h4> <ul> <li> Interaction_Details: Pippali’s active alkaloid piperine alters warfarin metabolism in animal models, changing metabolite levels and affecting anticoagulant response (INR) - effects can be unpredictable. <li> Severity: Severe <li> Recommendation: Avoid combining Pippali/piperine supplements with warfarin unless under specialist supervision with frequent INR monitoring; preferable to avoid. <li> Scientific_Study_Available: Yes <li> Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/32607007/ <li> Scientific_Study_Title: Piperine alters the pharmacokinetics and anticoagulation of warfarin in rats. <li> Scientfic_Study_Authors: Zayed MA, Aboul-Enein HY, et al. <li> Scientific_Study_Excerpt: <p>In a controlled rat study, co-administration of piperine with warfarin significantly altered the pharmacokinetics of warfarin’s major hydroxy metabolite and led to a measurable change in anticoagulation (INR) at 24 hours. Piperine inhibited enzymes involved in warfarin metabolism and also potentially affected gastrointestinal absorption and plasma protein binding; overall the interaction produced an unexpected reduction in warfarin’s anticoagulant effect in this model. Authors recommend clinical investigation and caution for patients on warfarin when piperine is co-administered.</p> </ul> <h4> CYP-metabolized narrow therapeutic index drugs (e.g., phenytoin, carbamazepine, certain antiarrhythmics)</h4> <ul> <li> Interaction_Details: Pippali/piperine inhibits multiple CYP enzymes (CYP1A2, CYP2C, CYP3A) and glucuronidation pathways, risking raised or lowered plasma levels of drugs metabolized by these enzymes. <li> Severity: Moderate <li> Recommendation: Consult your prescribing clinician before taking Pippali with antiepileptic drugs, some antiarrhythmics, or immunosuppressants; dose adjustments or monitoring may be required. <li> Scientific_Study_Available: Yes <li> Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/3917507/ <li> Scientific_Study_Title: Biochemical basis of enhanced drug bioavailability by piperine: evidence that piperine is a potent inhibitor of drug metabolism. <li> Scientfic_Study_Authors: Bhardwaj RK, Glaeser H, Becquemont L, Klotz U, Gupta SK, Fromm MF. <li> Scientific_Study_Excerpt: <p>Biochemical and pharmacologic investigations reveal that piperine causes dose-dependent inhibition of several hepatic microsomal reactions and enzyme systems (aryl hydrocarbon hydroxylase, ethylmorphine N-demethylase, UDP-glucuronyltransferase). Oral piperine prolonged pharmacologic effects of drugs in animals and inhibited several drug-metabolism pathways in vitro. The broad, non-specific enzyme inhibition documented indicates potential for clinically meaningful interactions with medicines that depend on these pathways, especially those with narrow therapeutic windows.</p> </ul> <h4> Drugs whose absorption is increased by efflux inhibition / P-gp substrates (e.g., digoxin, fexofenadine, some chemotherapy agents)</h4> <ul> <li> Interaction_Details: Pippali can inhibit intestinal efflux transporters (MRP2, BCRP, and modulate P-gp), increasing absorption and tissue uptake of transporter substrates and potentially increasing their effects or toxicity. <li> Severity: Moderate <li> Recommendation: Avoid unsupervised use with P-gp/BCRP/MRP2 substrate drugs; discuss with a clinician and consider monitoring drug levels where applicable. <li> Scientific_Study_Available: Yes <li> Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/30668388/ <li> Scientific_Study_Title: Piperine enhances the bioavailability of silybin via inhibition of efflux transporters BCRP and MRP2. <li> Scientfic_Study_Authors: Lin L, Gao Y, et al. <li> Scientific_Study_Excerpt: <p>In experimental models, piperine increased the oral bioavailability of silybin substantially by inhibiting efflux transporters BCRP and MRP2 (but not MDR1) in intestinal cell lines and sandwich-cultured hepatocytes; piperine also reduced biliary excretion of conjugates. The transporter inhibition and altered excretory behavior explain enhanced plasma exposure and therapeutic effect of co-administered substrates and suggests a risk of increased exposure/toxicity for drugs that are transporter substrates.</p> </ul> <h4> Propranolol, Theophylline and similar CYP substrate drugs (examples from human studies)</h4> <ul> <li> Interaction_Details: Human studies show piperine supplementation (20 mg/day) can increase Cmax and AUC for propranolol and theophylline, changing onset and duration of action. <li> Severity: Mild <li> Recommendation: Discuss with your clinician if you take these drugs; dosing or monitoring adjustments may be needed in some individuals. <li> Scientific_Study_Available: Yes <li> Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/1815977/ <li> Scientific_Study_Title: Effect of piperine on bioavailability and pharmacokinetics of propranolol and theophylline in healthy volunteers. <li> Scientfic_Study_Authors: Atal CK, Dubey RK, Singh J. <li> Scientific_Study_Excerpt: <p>In a crossover study in healthy volunteers, daily piperine (20 mg) for 7 days altered pharmacokinetic profiles of propranolol (earlier Tmax, higher Cmax, increased AUC) and theophylline (higher Cmax, longer half-life, higher AUC). The results indicate piperine increases systemic exposure and prolongs elimination for some drugs in humans, consistent with biochemical effects on metabolism and transport. Clinicians should be aware of these potential interactions for drugs with clinical sensitivity to plasma level changes.</p> </ul>